| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |